Publication | Closed Access

The protein corona hampers the transcytosis of transferrin-modified nanoparticles through blood–brain barrier and attenuates their targeting ability to brain tumor

NanoparticlesNanomedicineProtein CoronaEngineeringBlood–brain BarrierMedicineTherapeutic NanomaterialsBrain TumorNano-drug DeliveryTumor TargetingBiomedical EngineeringPharmacologyProtein Nanoparticles